The roles and effectiveness of adjunctive therapy in the management of musculoskeletal infections

Musculoskeletal Infections

Volumn , Issue , 2003, Pages 555-586

  Wang, Jue ^a   Calhoun, Jason H ^a   Mader, Jon T ^b   LeFrock, Jack ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2342592847     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (112)

1. FAWaldvogel, G Medoff, MN Swartz. Treatment of osteomyelitis. N Engl J Med 283(15):822, 1970.
2. JT Mader, ME Shirtliff, SC Bergquist, JH Calhoun. Antimicrobial treatment of chronic osteomyelitis. Clin Orthop 360:47-65, 1999.
3. GR Seabrook, CE Edmiston, DD Schmitt, C Krepel, DF Bandyk, JB Towne. Comparison of serum and tissue antibiotic levels in diabetes-related foot infections. Surgery 110(4):671-676, 1991.
4. SL Henry, KP Galloway. Local antibacterial therapy for the management of orthopaedic infections. Pharmacokinetic considerations. Clin Pharmacokinet 29(1):36-45, 1995.
5. JH Calhoun, JT Mader. Antibiotic beads in the management of surgical infections. Am J Surg 157(4):443-449, 1989.
6. AK Jain, R Panchagnula. Skeletal drug delivery systems. Int J Pharm 206(1-2):1-12, 2000.
7. J Ciampolini, KG Harding. Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often? Postgrad Med 76(898):479-483, 2000.
8. HW Buchholz, H Engelbrecht. Depot effects of various antibiotics mixed with Palacos resins. Chirurg 41(11):511-515, 1970.
9. HW Buchholz, RA Elson, E Engelbrecht, H Lodenkamper, J Rottger, A Siegel. Management of deep infection of total hip replacement. J Bone Joint Surg Br 63B(3):342-353, 1981.
10. B Roeder, CC Van Gils, S Maling. Antibiotic beads in the treatment of diabetic pedal osteomyelitis. J Foot Ankle Surg 39(2):124-130, 2000.
11. JH Calhoun, SL Henry, DM Anger, JA Cobos, JT Mader. The treatment of infected nonunions with gentamicin-polymethylmethacrylate antibiotic beads. Clin Orthop 295:23-27, 1993.
12. PA Ostermann, D Seligson, SL Henry. Local antibiotic therapy for severe open fractures: a review of 1085 consecutive cases. J Bone Joint Surg Br 77B(1):93-97, 1995.
13. DE Stabile, AM Jacobs. Local antibiotic treatment of soft tissue and bone infections of the foot. J Am Podiatr Med Assoc 80(7):345-353, 1990.
14. GJ Popham, P Mangino, D Seligson, SL Henry. Antibiotic-impregnated beads. Factors in antibiotic selection. Orthop Rev 20(4):331-337, 1991.
15. K Adams, L Couch, G Cierny, J Calhoun, JT Mader. In vitro and in vivo evaluation of antibiotic diffusion from antibiotic-impregnated polymethylmethacrylate beads. Clin Orthop 278:244-252, 1992.
16. JB Eckman, SL Henry, PD Manino, D Seligson. Wound and serum levels of tobramycin with the prophylactic use of tobramycin impregnated polymethylmethacrylate beads in compund fractures. Clin Orthop 237: 213-215, 1988.
17. RP Evans, CL Nelson. Gentamicin-impregnated polymethylmethacrylate beads compared with systemic antibiotic therapy in the treatment of chronic osteomyelitis. Clin Orthop 295:37-42, 1993.
18. GS Heard, LM Oloff, DA Wolfe, MD Little, DD Prins. PMMA bead versus parenteral treatment of Staphylococcus aureus osteomyelitis. J Am Podiatr Med Assoc 87(4):153-164, 1997.
19. JD Blaha, CL Nelson, LF Frevert, SL Henry, D Seligson, JL Esterhai Jr, RB Heppenstal, J Calhoun, J Cobos, J Mader. The use of septopal (polymethylmethacrylate beads with gentamicin) in the treatment of chronic osteomyelitis. Instr Course Lect 39:509-514, 1990.
20. JH Calhoun, JT Mader. Treatment of osteomyelitis with a biodegradable antibiotic implant. Clin Orthop 341:206-214, 1997.
21. G Josefsson, L Lindberg, B Wiklander. Systemic antibiotics and gentamicincontaining bone cement in the prophylaxis of postoperative infections in total hip arthroplasty. Clin Orthop 159:194-200, 1981.
22. GH Walenkamp, LL Kleijn, M de Leeuw. Osteomyelitis treated with gentamicin-PMMA beads: 100 patients followed for 1-12 years. Acta Orthop Scand 69(5):518-522, 1998.
23. K Kanellakopoulou, EJ Giamarellos-Bourboulis. Carrier systems for the local delivery of antibiotics in bone infections. Drugs 59(6):1223-1232, 2000.
24. Y Takezawa, Y Doi, S Shibata, K Uno, T Horiguchi, N Wakamatsu, H Kamemizu, T Gyotoku, M Adachi, Y Moriwaki. Self-setting apatite cement. 6. Possibility as bone substitute. Jpn J Oral Biol 31(3):240-247, 1989.
25. LC Chow, WE Brown. A physicochemical bench-scale caries model. J Dent Res 63(6):868-873, 1984.
26. M Otsuka, Y Matsuda, D Yu, J Wong, JL Fox, WI Higuchi. A novel skeletal drug delivery system for anti-bacterial drugs using self-setting hydroxyapatite cement. Chem Pharm Bull (Tokyo) 38(12):3500-3502, 1990.
27. S Sasaki, Y Ishii. Apatite cement containing antibiotics: efficacy in treating experimental osteomyelitis. J Orthop Sci 4(5):361-369, 1999.
28. J Guicheux, G Grimandi, M Trecant, A Faivre, S Takahashi, G Daculsi. Apatite as carrier for growth hormone: in vitro characterization of loading and release. J Biomed Mater Res 34(2):165-170, 1997.
29. A Kamegai, N Shimamura, K Naitou, K Nagahara, N Kanematsu, M Mori. Bone formation under the influence of bone morphogenetic protein=self-setting apatite cement composite as a delivery system. Biomed Mater Eng 4(4):291-307, 1994.
30. Y Shinto, A Uchida, F Korkusuz, N Araki, K Ono. Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J Bone Joint Surg Br 74B(4):660-664, 1992.
31. BD Solberg, AP Gutow, MR Baumgaertner. Efficacy of gentamycin-impregnated resorbable hydroxyapatite cement in treating osteomyelitis in a rat model. J Orthop Trauma 13(2):102-106, 1999.
32. Y Yamashita, A Uchida, I Yamakawa, Y Shinto, N Araki, K Kato. Treatment of chronic osteomyelitis using calcium hydroxyapatite ceramic implants impregnated with antibiotic. Int Orthop 22(4):247-251, 1998.
33. JA Jansen, JP van de Waerden, JG Wolke, K de Groot. Histologic evaluation of the osseous adaptation to titanium and hydroxyapatite-coated titanium implants. J Biomed Mater Res 25(8):973-989, 1991.
34. G Wei, Y Kotoura, M Oka, T Yamamuro, R Wada, SH Hyon, Y Ikada. A bioabsorbable delivery system for antibiotic treatment of osteomyelitis: The use of lactic acid oligomer as a carrier. J Bone Joint Surg Br 73B(2):246-252, 1991.
35. W Amass, A Amass, B Tighe. A review of biodegradable polymers: uses, current developments in the synthesis and characterization of biodegradable polyesters, blends of biodegradable polymers and recent advances in biodegradation studies. Polym Int 47:89, 1998.
36. J B Turesin, I Gursel, V Hasirci. Biodegradable polyhydroxyalkanoate implants for osteomyelitis therapy: in vitro antibiotic release. J Biomater Sci Polym Ed 12(2):195-207, 2001.
37. JD Meyer, RF Falk, RM Kelly, JE Shively, SJ Withrow, WS Dernell, DJ Kroll, TW Randolph, MC Manning. Preparation and in vitro characterization of gentamycinimpregnated biodegradable beads suitable for treatment of osteomyelitis. J Pharm Sci 87(9):1149-1154, 1998.
38. JH Calhoun, JT Mader. Treatment of osteomyelitis with a biodegradable antibiotic implant. Clin Orthop 341:206-214, 1997.
39. KL Garvin, JA Miyano, D Robinson, D Giger, J Novak, S Radio. Polylactide= polyglycolide antibiotic implants in the treatment of osteomyelitis: a canine model. J Bone Joint Surg Am 76A(10):1500-1506, 1994.
40. ST Boyce, IA Holder, AP Supp, GD Warden, DC Greenhalgh. Delivery and activity of antimicrobial drugs released from human fibrin sealant. J Burn Care Rehabil 15(3):251-255, 1994.
41. DF Thompson, TW Davis. The addition of antibiotics to fibrin glue. South Med J 90(7):681-684, 1997.
42. MS Park, YB Kim. Sustained release of antibiotic from a fibrin-gelatin-antibiotic mixture. Laryngoscope 107(10):1378-1381, 1997.
43. H Redl, G Schlag, G Stanek, A Hirschl, T Seelich. In vitro properties of mixtures of fibrin seal and antibiotics. Biomaterials 4(1):29-32, 1983.
44. H Zilch, E Lambiris. The sustained release of cefotaxim from a fibrin-cefotaxim compound in treatment of osteitis: pharmacokinetic study and clinical results. Arch Orthop Trauma Surg 106(1):36-41, 1986.
45. JD Blaha, JH Calhoun, CL Nelson, SL Henry, D Seligson, JL Esterhai Jr, RB Heppenstall, J Mader, RP Evans, J Wilkins. Comparison of the clinical efficacy and tolerance of gentamicin PMMA beads on surgical wire versus combined and systemic therapy for osteomyelitis. Clin Orthop (295):8-12, 1993.
46. JM Wozney, V Rosen, AJ Celeste, LM Mitsock, MJ Whitters, RW Kriz, RM Hewick, EA Wang. Novel regulators of bone formation: molecular clones and activities. Science 242(4885): 1528-1534, 1988.
47. W Friess, H Uludag, S Foskett, R Biron, C Sargeant. Characterization of absorbable collagen sponges as recombinant human bone morphogenetic protein-2 carriers. Int J Pharm 185(1):51-60, 1999.
48. GE Riedel, A Valentin-Opran. Clinical evaluation of rhBMP-2=ACS in orthopedic trauma: a progress report. Orthopedics 22(7):663-665, 1999.
49. MW Chapman, R Bucholz, C Cornell. Treatment of acute fractures with a collagencalcium phosphate graft material. A randomized clinical trial. J Bone Joint Surg Am 79A(4):495-502, 1997.
50. GE Friedlaender, CR Perry, JD Cole, SD Cook, G Cierny, GF Muschler, GA Zych, JH Calhoun, AJ LaForte, S Yin. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83A(suppl 1 pt 2):S151-S158, 2001.
51. EE Johnson, MR Urist, GA Finerman. Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein: a preliminary report. Clin Orthop 236:249-257, 1988.
52. M Kawamura, MR Urist. Human fibrin is a physiologic delivery system for bone morphogenetic protein. Clin Orthop 235:302-310, 1988.
53. EJ Caterson, LJ Nesti, WJ Li, KG Danielson, TJ Albert, AR Vaccaro, RS Tuan. Three-dimensional cartilage formation by bone marrow-derived cells seeded in polylactide=alginate amalgam. J Biomed Mater Res 57(3):394-403, 2001.
54. P Rokkanen, O Bostman, S Vainionpaa, K Vihtonen, P Tormala, J Laiho, J Kilpikari, M Tamminmaki. Biodegradable implants in fracture fixation: early results of treatment of fractures of the ankle. Lancet 1(8443):1422-1424, 1985.
55. PU Rokkanen. Bioabsorbable fixation devices in orthopaedics and traumatology. Ann Chir Gynaecol 87(1):13-20, 1998.
56. O Bostman, S Vainionpaa, E Hirvensalo, A Makela, K Vihtonen, P Tormala, P Rokkanen. Biodegradable internal fixation for malleolar fractures: a prospective randomised trial. J Bone Joint Surg Br 69B(4):615-619, 1987.
57. HH Peltoniemi, RM Tulamo, T Toivonen, D Hallikainen, P Tormala, T Waris. Biodegradable semirigid plate and miniscrew fixation compared with rigid titanium fixation in experimental calvarial osteotomy. J Neurosurg 90(5):910-917, 1999.
58. T Yamamuro, Matsusue Y, Uchida A, Shimada K, Shimozaki E, Kitaoka K. Bioabsorbable osteosynthetic implants of ultra high strength poly-L-lactide: a clinical study. Int Orthop 18(6):332-340, 1994.
59. I Yasuda. Fundamental aspects of fracture treatment. J Kyoto Med Soc 4:395-406, 1953.
60. F Benazzo, M Mosconi, G Beccarisi, U Galli. Use of capacitive coupled electric fields in stress fractures in athletes. Clin Orthop 310:145-149, 1995.
61. V Cane, P Botti, S Soana. Pulsed magnetic fields improve osteoblast activity during the repair of an experimental osseous defect. J Orthop Res 11:664-670, 1993.
62. KL Grace, WJ Revell, M Brookes. The effects of pulsed electromagnetism on fresh fracture healing: osteochondral repair in the rat femoral groove. Orthopedics 21:297-302, 1998.
63. JG Fleischli, TJ Laughlin. Electrical stimulation in wound healing. J Foot Ankle Surg 36(6):457-461, 1997.
64. OM Alvarez, PM Mertz, RV Smerbeck, WH Eaglstein. The healing of superficial skin wounds is stimulated by external electrical current. J Invest Dermatol 81(2):144-148, 1983.
65. M Brown, MK McDonnell, DN Menton. Polarity effects on wound healing using electric stimulation in rabbits. Arch Phys Med Rehabil 70(8):624-627, 1989.
66. L Bolton, B Foleno, B Means, S Petrucelli. Direct-current bactericidal effect on intact skin. Antimicrob Agents Chemother 18(1):137-141, 1980.
67. K Tamura. Some effects of weak direct current and silver ions on experimental osteomyelitis and their clinical application. Nippon Seikeigeka Gakkai Zasshi 57(2):187-197, 1983.
68. BA Rouley, J Mckenna, G Chase. The influence of electrical current on an infecting organism in wounds. Ann N Y Acad Sci 238:543-551, 1974.
69. T Bodamyali, B Bhatt, FJ Hughes, VR Winrow, JM Kanczler, B Simon, J Abbott, DR Blake, CR Stevens. Pulsed electromagnetic fields simultaneously induce osteogenesis and upregulate transcription of bone morphogenetic protein 2 and 4 in rat osteoblasts in vitro. Biochem Biophys Res Commun 250:458-461, 1998.
70. A Yajima, M Ochi, Y Hirose, O Nakade, Y Abiko, T Kaku, K Sakaguchi. Effects of pulsing electromagnetic fields on gene expression of bone morphogenetic proteins in human osteoblastic cell line in vitro (Abstract T326). J Bone Miner Res 11(suppl 1):S381, 1996.
71. H Wiesmann, M Hartig, U Stratmann, U Meyer, U Joos. Electrical stimulation influences mineral formation of osteoblast-like cells in vitro. Biochim Biophys Acta 1538(1):28-37, 2001.
72. ZB Friedenberg, MC Harlow, CT Brighton. Healing of nonunion of the medial malleolus by means of direct current: a case report. J Trauma 11(10):883-885, 1971.
73. HR Gossling, RA Bernstein, J Abbott. Review: treatment of ununited tibial fracture:a comparison of surgery and PEMF. Orthopedics 15(6):711-719, 1992.
74. G Scott, JB King. A prospective, double-blind trial of electrical capacitive coupling in the treatment of non-union of long bones. J Bone Joint SurgAm 76A:820-826, 1994.
75. DE Garland, B Moses, W Salyer. Long term follow up of fracture non-unions treated with PEMF. Contemp Orthop 22(3):295-302, 1991.
76. AF Dwyer, GG Wickham. Direct current stimulation in spinal fusion. Med J Aust 1(3):73-75, 1974.
77. V Mooney. A randomized double-blind prospective study of the efficacy of pulsed electromagnetic fields for interbody lumbar fusions. Spine 15(7):708-712, 1990.
78. RK Aaron, DM Ciombor, G Jolly. Stimulation of experimental endochondral ossification by low-energy pulsing electromagnetic fields. J Bone Miner Res 4:227-233, 1989.
79. B Baker, J Spadaro, A Marino, RO Becker. Electrical stimulation of articular cartilage regeneration. Ann N Y Acad Sci 238:491-499, 1974.
80. H Liu, J Abbott, JA Bee. Pulsed electromagnetic fields influence hyaline cartilage extracellular matrix composition without affecting molecular structure. Osteoarthritis Cartilage 4:63-76, 1996.
81. DA Grande, FP Magee, AM Weinstein, BR McLeod. The effect of low-energy combined AC and DC magnetic fields on articular cartilage metabolism. Ann NY Acad Sci 635:404-407, 1991.
82. R Goodman, CA Bassett, AS Henderson. PEMF induced cellular transcription. Science 220:1283-1285, 1983.
83. AR Liboff, T Williams, DM Strong, R Wistar Jr. Time varying magnetic fields:effect on DNA synthesis. Science 223:818-819, 1984.
84. J Feedar, L Kloth, G Gentzkow. Chronic dermal ulcer healing enhanced with monophasic pulsed electrical stimulation. Phys Ther 72(7):539, 1992.
85. SE Gardner, RA Frantz, FL Schmidt. Effect of electrical stimulation on chronic wound healing: a meta-analysis. Wound Repair Regen 7(6):495-503, 1999.
86. RK Olney, YT So, DS Goodin. A comparison of magnetic and electrical stimulation of peripheral nerves. Muscle Nerve 13:957-963, 1990.
87. LL Lednev. Possible mechanisms of weak magnetic fields on biological systems. Bioelectromagnetics 12:71-75, 1991.
88. MI Weintraub. Chronic submaximal magnetic stimulation in peripheral neuropathy. Am J Pain Manag 8:12-16, 1998.
89. A Weinberger, A Nyska, S Giler. Treatment of experimental inflammatory synovitis with continuous magnetic field. Isr J Med Sci 32:1197-1201, 1996.
90. DH Trock, AJ Bollet, R Markoll. The effect of PEMF in the treatment of OA of the knee and cervical spine. J Rheumatol 21:1903-1911, 1994.
91. DH Trock, AJ Bollet, RH Dyer, LP Fielding, WK Miner, R Markoll. A doubleblind trial of the clinical effects of PEMF in osteoarthritis. J Rheumatol 20(3):456-460, 1993.
92. TM Zizic, KC Hoffman, PA Holt, DS Hungerford, JR O’Dell, MA Jacobs, CG Lewis, CL Deal, JR Caldwell, JG Cholewczynski. The treatment of osteoarthritis of the knee with pulsed electrical stimulation. J Rheumatol 22(9):1757-1761,1995.
93. PJ Cundy, DC Paterson. A ten-year review of treatment of delayed union and nonunion with an implanted bone growth stimulator. Clin Orthop 259:216-222, 1990.
94. WJ Broad. Cancer fear is unfounded, physicists say: power line concern is called needless. The New York Times, May 14, 1995.
95. EM Camporesi, ed. Hyperbaric Oxygen Therapy Committee Report. Kensington, MD: Undersea and Hyperbaric Medical Society, 1996.
96. JC Davis, JM Dunn, RD Heimbach. Indications for hyperbaric oxygen therapy. Tex Med 76(8):44-47, 1980.
97. JT Mader, GL Brown, JC Guckian, CH Wells, JA Reinarz. A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. J Infect Dis 142(6):915-922, 1980.
98. JT Mader, CA Hicks, J Calhoun. Bacterial osteomyelitis: adjunctive hyperbaric oxygen therapy. Orthop Rev 18(5):581-585, 1989.
99. G Cierny, JT Mader, HA Pennick. Clinical staging system of adult osteomyelitis. Contemp Orthop 10:17-37, 1985.
100. JH Calhoun, JA Cobos, JT Mader. Does hyperbaric oxygen have a place in the treatment of osteomyelitis? Orthop Clin North Am 22(3):467-471, 1991.
101. JT Mader, KR Adams, WR Wallace, JH Calhoun. Hyperbaric oxygen as adjunctive therapy for osteomyelitis. Infect Dis Clin North Am 4(3):433-440, 1990.
102. JL Esterhai Jr, J Pisarello, CT Brighton, RB Heppenstall, H Gellman, G Goldstein. Adjunctive hyperbaric oxygen therapy in the treatment of chronic refractory osteomyelitis. J Trauma 27(7):763-768, 1987.
103. CY Chen, SS Lee, YS Chan, CY Yen, EK Chao, SW Ueng. Chronic refractory tibia osteomyelitis treated with adjuvent hyperbaric oxygen: a preliminary report. Chang gengYi Xue Za Zhi 21(2):165-171, 1998.
104. JC Davis, JD Heckman, JC DeLee, FJ Buckwold. Chronic non-hematogenous osteomyelitis treated with adjuvant hyperbaric oxygen. J Bone Joint Surg Am 68A(8):1210-1217, 1986.
105. E Faglia, F Favales, A Aldeghi, P Calia, A Quarantiello, G Oriani, M Michael, P Campagnoli, A Morabito. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer: a randomized study. Diabetes Care 19(12):1338-1343, 1996.
106. N Doctor, S Pandya, A Supe. Hyperbaric oxygen therapy in diabetic foot. Postgrad Med 38(3):111, 112-114, 1992.
107. MR Hamilton-Farrel. Fourth Consensus Conference of the European Committee on Hyperbaric Medicine. Diabetes Nutr Metab 12(1):47-48, 1999.
108. ME Sutherland, AA Meyer. Necrotizing soft tissue infections. Surg CIin North Am 74:591-607, 1994.
109. JA Riseman, WA Zamboni, A Curtis, DR Graham, HR Konrad, DS Ross. Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for débridements. Surgery 108(5):847-850, 1990.
110. GB Hart, RC Lamb, MB Strauss. Gas gangrene. J Trauma 23(11):991-1000, 1983.
111. C Plafki, P Peters, M Almeling, W Welslau, R Busch. Complications and side effects of hyperbaric oxygen therapy. Aviat Space Environ Med 71(2):119-124, 2000.
112. HW Buchholz, H Engelbrecht. Uber die deportwirkung einiger antibiotica bei vermischung mit dem Kunstharz palacos. Chirug 41:511-515, 1970.